Market Research Logo

Needle-Free Devices, Technologies and Global Markets

Needle-Free Devices, Technologies and Global Markets

The global market for needle free technologies reached $963.6 million in 2013. This market is expected to grow to $1.1 billion in 2014 and $2.1 billion in 2019, with a compound annual growth rate (CAGR) of 14.3%.

This report provides:

An overview of the global market for stem cells and related technologies.

Analyses of global market trends, with data from 2013, estimates for 2014, and projections of compound annual growth rates (CAGRs) through 2019.

A regional breakdown of the market with emphasis on the U.S., Europe, and Japan

Qualitative and quantitative factors that are driving the global needle free devices market

Analysis of needle free drug delivery devices including jet injectors, inhalers, transdermal patch and other novel needle technologies

Discussion on market strategy, the competitive landscape, regulatory structure, and pricing and reimbursement for the industry

Comprehensive company profiles of major players in the field.


SCOPE OF THE REPORT

This report is an analytical business tool whose primary purpose is to describe the thorough evaluation of the global market for needle-free devices and technologies. The format of the study is organized around the following topics:

Detailed study around key diseases such as asthma and diabetes.

Detailed study around key issues associated with traditional needle-based drug delivery devices and technologies, including needle phobia and needlestick injuries.

Incidence needlestick injuries and prevalence of chronic diseases such as asthma and diabetes.

Regulatory structure.

Market characterization, segmentation and unmet need.

Market size of needle-free devices and technologies, excluding the market for drug sales, combined with various needle-free devices such as needle-free injectors, transdermal patches, inhalers and other novel needle technologies.

Market drivers and restraints.

Detailed market projections through 2019.

Competition and market shares.

Pricing and reimbursement.

Marketed and pipeline (research and development) products along with description, regulatory status and clinical trials.

Market strategy along with key mergers, acquisitions, partnership agreements and other company developments.

Observations and conclusions regarding the future market of needle-free devices and technologies.

CHAPTER 1 INTRODUCTION
NEEDLE-FREE DEVICES
STUDY BACKGROUND
STUDY GOALS AND OBJECTIVES
INTENDED AUDIENCE
SCOPE OF THE REPORT
METHODOLOGY AND INFORMATION SOURCES
ANALYST'S CREDENTIALS
RELATED BCC RESEARCH REPORTS
BCC RESEARCH WEBSITE
DISCLAIMER
CHAPTER 2 SUMMARY
EXECUTIVE SUMMARY
SUMMARY TABLE GLOBAL MARKET FOR NEEDLE-FREE TECHNOLOGIES, THROUGH 2019 ($ MILLIONS)
SUMMARY FIGURE GLOBAL MARKET FOR NEEDLE-FREE TECHNOLOGIES, 2013-2019 ($ MILLIONS)
CHAPTER 3 DRUG DELIVERY DEVICES
STRUCTURE OF HUMAN SKIN
EPIDERMIS
DERMIS
HYPODERMIS
OVERVIEW OF DRUG DELIVERY SYSTEMS AND TECHNOLOGIES
CLASSIFICATION OF DRUG DELIVERY ACCORDING TO TECHNOLOGY
SUSTAINED RELEASE DRUG DELIVERY
PRODRUGS
IMPLANTS AND INTRAUTERINE DEVICES
TARGETED DRUG DELIVERY
POLYMERIC DRUG DELIVERY
CLASSIFICATION OF DRUG DELIVERY BY ROUTE OF ADMINISTRATION
ORAL DRUG DELIVERY
Proteins and Peptides
Enzyme Inhibitors
Mucoadhesives
Encapsulation Technologies
TABLE 1 ADVANTAGES AND DISADVANTAGES OF ORAL DRUG
DELIVERY
INJECTABLE OR PARENTERAL DRUG DELIVERY
Needle/Syringe Injections
Safety Syringes/Needle-Free Injectors
TABLE 2 ADVANTAGES AND DISADVANTAGES OF INJECTABLE DRUG
DELIVERY
PULMONARY DRUG DELIVERY
TABLE 3 ADVANTAGES AND DISADVANTAGES OF PULMONARY DRUG
DELIVERY
NASAL DRUG DELIVERY
TABLE 4 ADVANTAGES AND DISADVANTAGES OF NASAL DRUG DELIVERY
ORAL MUCOSAL DRUG DELIVERY
TABLE 5 ADVANTAGES AND DISADVANTAGES OF ORAL MUCOSAL
DELIVERY
RECTAL DRUG DELIVERY
TABLE 6 ADVANTAGES AND DISADVANTAGES OF RECTAL DRUG
DELIVERY
OCULAR DRUG DELIVERY
TABLE 7 ADVANTAGES AND DISADVANTAGES OF OCULAR DRUG
DELIVERY
TRANSDERMAL DRUG DELIVERY
Passive Methods
Active Methods
Combined Technologies
TABLE 8 ADVANTAGES AND DISADVANTAGES OF TRANSDERMAL
DRUG DELIVERY
NEED FOR BETTER METHODS OF DRUG DELIVERY
AREAS OF ONGOING RESEARCH
CHAPTER 4 NEEDLE-FREE TECHNOLOGY AND DRUG DELIVERY DEVICES
NEEDLE-FREE DRUG DELIVERY DEVICES AND TYPES
HISTORY OF NEEDLE-FREE DEVICES
MARKET NEED FOR NEEDLE-FREE DEVICES
NEEDLE PHOBIA
Vasovagal
Associative
Resistive
Hyperalgesic
Vicarious
NEEDLESTICK INJURY
Overview of Needlestick Injury
Incidence of Needlestick Injuries
TABLE 9 INCIDENCE OF NEEDLESTICK INJURIES BY GEOGRAPHY, 2013 (NO.)
FIGURE 1 INCIDENCE OF NEEDLESTICK INJURIES BY GEOGRAPHY, 2013 `(% OF TOTAL)
Causes of Sharps Injuries
Cost of Needlestick Injuries
Needlestick Injury Prevention
ADVANTAGES OF NEEDLE-FREE TECHNOLOGY
CHAPTER 5 NEEDLE-FREE DEVICE APPLICATIONS
APPLICATION OF NEEDLE-FREE DEVICES
TABLE 10 GLOBAL NEEDLE-FREE TECHNOLOGIES MARKET BY SEGMENT, THROUGH 2019 ($ MILLIONS)
FIGURE 2 GLOBAL NEEDLE-FREE TECHNOLOGIES MARKET BY SEGMENT, 2013-2019 ($ MILLIONS)
PAIN MANAGEMENT
Latest Developments in Needle-Free Pain Management
VACCINE DELIVERY
Latest Developments in Needle-Free Vaccine Delivery
Future Developments in Needle-Free Vaccine Delivery
INSULIN DELIVERY
Diabetes Overview
FIGURE 3 DISTRIBUTION OF DIABETES TYPES GLOBALLY, 2013 (% OF TOTAL DIABETES)
Epidemiology and Economic Burden
TABLE 11 PREVALENCE OF DIABETES BY GEOGRAPHY, 2013 ($ MILLIONS)
FIGURE 4 PREVALENCE OF DIABETES BY GEOGRAPHY, 2013` (% OF TOTAL)
Traditional Insulin Delivery Systems
Needle-Free Insulin Delivery Systems
Insulin Jet Injectors
Inhalable Insulin Devices
Insulin Spray Systems
Insulin Micropump
Insulin Port
Transdermal Insulin Patches
Insulin Nanopump
TABLE 12 COMPARISON BETWEEN PAINFUL AND PAINLESS
NEEDLE-FREE INSULIN DRUG DELIVERY SYSTEMS
Future Prospective for Needle-Free Insulin Delivery Systems
PEDIATRIC DRUG DELIVERY
Needle-Free Injectors
Low Workload Jet Injectors for Routine Immunizations
Multi-Channel Jet Injectors for Simultaneous Vaccine Delivery
Transdermal Methods and Microneedle Technologies for Various Drug
Delivery Applications
CHAPTER 6 NEEDLE-FREE INJECTORS
INTRODUCTION
HISTORICAL BACKGROUND OF NEEDLE-FREE INJECTOR
CLINICAL NEED FOR NEEDLE-FREE INJECTORS
NEEDLE-FREE INJECTOR TYPES
NEEDLE-FREE INJECTORS TYPES BY MEDICATION
Liquid-Based Needle-Free Injectors
Powder-Based Needle-Free Injectors
Depot or Projectile Needle-Free injectors
NEEDLE-FREE INJECTOR TYPES BY DRUG DELIVERY
Intramuscular Injections
Subcutaneous Injections
Intradermal Injections
NEEDLE-FREE INJECTOR TYPES BY SOURCE OF POWER
Spring Powered
Compressed Gas Powered
NEEDLE-FREE INJECTORS BY USAGE TYPE
Single-Use Injectors
Disposable Injectors
Reusable Injectors
COMPONENTS OF NEEDLE-FREE INJECTORS
INJECTOR DEVICE AND DRUG RESERVOIR
NOZZLE
PRESSURE SOURCE
MECHANISM OF OPERATION
RAW MATERIALS AND KEY NEEDLE-FREE INJECTOR DESIGNS
RAW MATERIALS
KEY NEEDLE-FREE INJECTOR DESIGNS
Jet Injectors
Jet Injector Gun
Hypodermal Jet Injectors without a Needle
Low Workload Jet Injector
Multi-Channel Jet Injector
Biojector
Microjets
Intraject Technology
Mini-Ject Technology
Needle-Free, Auto and Pen Injectors
MadaJet
INJEX Needle-Free Injectors for Infiltration Anesthesia
NEEDLE-FREE INJECTOR APPLICATIONS
ADVANTAGES AND DISADVANTAGES OF NEEDLE-FREE INJECTORS
EFFICIENT DRUG DISTRIBUTION AND IMPROVED EFFICACY
GREATER PATIENT ACCEPTANCE AND COMPLIANCE
TABLE 13 ADVANTAGES AND DISADVANTAGES OF NEEDLE-FREE
INJECTORS
SUPERIOR SAFETY
RELIABILITY AND REPEATABILITY
FASTER INJECTION TIME
ELIMINATES SHARPS WASTE
CLINICAL CHALLENGES AND UNMET NEEDS
FUTURE DEVELOPMENTS
CHAPTER 7 INHALER TECHNOLOGIES
PULMONARY DRUG DELIVERY
TABLE 14 IDEAL CHARACTERISTICS OF THERAPEUTIC AEROSOLS
TABLE 15 ADVANTAGES AND DISADVANTAGES OF PULMONARY DRUG
DELIVERY
INHALER TECHNOLOGY
TABLE 16 ADVANTAGES AND DISADVANTAGES OF INHALER
TECHNOLOGIES
HISTORICAL BACKGROUND
CLINICAL NEED FOR INHALER TECHNOLOGY
Epidemiology of Asthma
TABLE 17 PREVALENCE OF ASTHMA BY GEOGRAPHY, 2013 (MILLIONS)
FIGURE 5 PREVALENCE OF ASTHMA BY GEOGRAPHY, 2013 (% OF TOTAL)
Economic Burden of Asthma
TYPES OF INHALERS
MDI
TABLE 18 ADVANTAGES AND DISADVANTAGES OF METERED DOSE
INHALERS
New Developments in MDI Technology
Advanced MDI and Use Enantiomer Preparations of Inhaled Drugs
Generic MDIs
Improved Patient Inhalation Coordination with Advanced MDI
Flow Gate Valve Technology in Spacers
Adaptive Aerosol Delivery Technology
Autohaler (Modified Form of pMDI)
TABLE 19 ADVANTAGES AND DISADVANTAGES OF F STANDARD
PRESS AND BREATHE METERED DOSE INHALERS
DPI
New Developments in DPI Technology
Air Classifier Technology in Devices
Multiple Air Classifier Technology
Spiros Inhaler Technology
TABLE 20 ADVANTAGES AND DISADVANTAGES OF DRY POWDER
INHALERS
MDI. vs DPI (Uniformity vs. Diversity)
TABLE 21 COMPARISON OF INHALERS: MDI VS. DPI
ADVANCES IN PULMONARY DRUG DELIVERY
Particle Engineering
Agglomerated Vesicle Technology
FUTURE DEVELOPMENTS
CHAPTER 8 TRANSDERMAL PATCH TECHNOLOGIES
TRANSDERMAL DRUG DELIVERY
TABLE 22 PARAMETERS AFFECTING SELECTION OF DRUGS IN TRANSDERMAL DRUG DELIVERY SYSTEMS
TRANSDERMAL PATCH TECHNOLOGY
TABLE 23 IDEAL PROPERTIES OF TRANSDERMAL DRUG DELIVERY SYSTEMS
CLINICAL NEED
HISTORICAL BACKGROUND
TYPES OF TRANSDERMAL PATCHES
Single-Layer Drug-in-Adhesive
Multilayer Drug-in-Adhesive
Reservoir
Matrix
Drug-in-Adhesive System
Matrix Dispersion System
Micro Reservoir System
Vapor Patch
TABLE 24 ADVANTAGES AND DISADVANTAGES OF TRANSDERMAL
PATCHES
COMPONENTS OF A TRANSDERMAL PATCH
Polymer Matrix
Drug
Permeation Enhancers
Adhesive
Backing Laminates
Release Liner
Other Excipients
BENEFITS OF TRANSDERMAL PATCHES OVER OTHER DOSAGE FORMS
NEW INNOVATIONS IN TRANSDERMAL PATCHES
Dispenser for Transdermal Patches
Magnetophoresis Combined with Chemical Enhancers
LIMITATIONS OF TRANSDERMAL PATCHES
CLINICAL ISSUES OF TRANSDERMAL DELIVERY
FUTURE DEVELOPMENTS
CHAPTER 9 OTHER NOVEL NEEDLE TECHNOLOGIES
MICRONEEDLES
HISTORICAL BACKGROUND
TYPES OF MICRONEEDLES
Solid Microneedles
Fabrication of Solid Microneedles
Silicon Microneedles
Metal Microneedles
Polymer Microneedles
Ceramic Microneedles
Microneedle Rollers
Coated Microneedles
Dissolving Microneedles
Hollow Microneedles
APPLICATION OF MICRONEEDLES
Blood Glucose Measurements
Transdermal Drug Delivery
Immunobiologicals
Bioactive Macromolecules (Biopharmaceuticals)
Drug Delivery
Diagnosis
Cosmetic Products
ADVANTAGES AND DISADVANTAGES OF MICRONEEDLES
TABLE 25 ADVANTAGES AND DISADVANTAGES OF MICRONEEDLES
ADVANCES IN DRUG DELIVERY BY MICRONEEDLES
CURRENT AND FUTURE DEVELOPMENTS
PEN NEEDLES
CONSTRUCTION AND DESIGN OF PEN NEEDLES
TABLE 26 ADVANTAGES AND DISADVANTAGES OF MICRONEEDLES
CURRENT AND FUTURE DEVELOPMENTS
CHAPTER 10 NEEDLE-FREE DEVICE MARKET ASSESSMENT
DRUG DELIVERY DEVICES
GLOBAL NEEDLE-FREE TECHNOLOGIES MARKET
GLOBAL MARKET BY GEOGRAPHIC REGION
TABLE 27 GLOBAL MARKET FOR NEEDLE-FREE TECHNOLOGIES BY REGION, THROUGH 2019 ($ MILLIONS)
FIGURE 6 GLOBAL MARKET FOR NEEDLE-FREE TECHNOLOGIES BY REGION, 2013-2019 ($ MILLIONS)
GLOBAL MARKET BY SEGMENT
TABLE 28 GLOBAL NEEDLE-FREE TECHNOLOGIES MARKET BY SEGMENT, THROUGH 2019 ($ MILLIONS)
FIGURE 7 GLOBAL NEEDLE-FREE TECHNOLOGIES MARKET BY SEGMENT, 2013-2019 ($ MILLIONS)
FIGURE 8 NEEDLE-FREE DRUG DELIVERY TECHNOLOGY MARKET BY SEGMENT, 2013 (% OF TOTAL MARKET)
GLOBAL MARKET BY APPLICATION
TABLE 29 GLOBAL NEEDLE-FREE TECHNOLOGY MARKET BY APPLICATION, THROUGH 2019 ($ MILLIONS)
FIGURE 9 NEEDLE-FREE TECHNOLOGY MARKET BY APPLICATION, 2013 (% OF TOTAL MARKET)
MARKET GROWTH DRIVERS AND RESTRAINTS
Growth Drivers
Increase in Disease Population Worldwide.
Needle Phobia and Increasing Awareness about the Risk of
Needlestick Injuries
Increasing Demand for Painless Drug Delivery Technologies
Growing Demand for Minimally Invasive Delivery Methods
Demand for More Sophisticated Delivery Systems for Effective
Treatment
Growing Demand for Drug-Device Combinations
Limitations of Oral Drug Delivery
Limitations of Hypodermic Needles
Growing Demand for Needle-Free Technologies for Chronic Pain
Management
Increasing Awareness about the Safety and Efficacy of Drug Delivery
Technologies
Rising Prevalence of Diabetes
Increasing Awareness about Pediatric Vaccinations
Increasing Use of Needle-Free Injections in Anesthesia Delivery
Booming Global Vaccine Market
Mass Immunization Programs
Cost-Efficient Drug Delivery
Growth of Biologics and Entry of Biosimilars in Leading
Pharmaceutical Markets
Development of Home-Care and Self-Medication Devices
Growing Market for Injectable Medications
Growing Market for Injectable HGH
Growth Restraints
High Cost of Needle-Free Technology
Increasing Regulatory Scrutiny and Inefficient Manufacturing
Processes
Downward Pricing Pressure, Increasing Material Cost and Inefficient
Manufacturing Processes
Increasing Competition and Decreasing Profit Margins
Increasing Research and Development Cost
Shorter Product Life Cycles
Risks and Complications
COMPETITIVE LANDSCAPE
TABLE 30 GLOBAL NEEDLE-FREE DEVICE MARKET REVENUE SHARES, 2013 ($ MILLIONS/%)
FIGURE 10 GLOBAL NEEDLE-FREE DEVICE MARKET LEADERS, 2013 (% OF TOTAL MARKET)
CHAPTER 11 MARKET STRATEGY
NEEDLE-FREE DEVICES MARKET STRATEGY
KEY STRATEGIC EVENTS DURING THE LAST FEW YEARS
TABLE 31 NEEDLE-FREE DEVICE MARKET, KEY MERGERS/ACQUISITIONS
Key Mergers and Acquisitions
OPKO Health's Acquisition of Inspiro Medical
Endo International’s Acquisition of Zogenix' DosePro Migraine
Therapy Business
North Coast Medical's Acquisition of ActivaTek
Teva Pharmaceutical's Acquisition of NuPathe
Teva Pharmaceutical's Acquisition of MicroDose Therapeutx
Becton Dickinson's Acquisition of Safety Syringes
Medical Marketing Berlin/Paketeria AG's Acquisition of INJEX Pharma
Key Product and Technology Developments
NxStage Announces FDA Clearance of a Single Needle Technology
Vaxxas' Nanopatch Garners WHO Support for Polio Vaccine Delivery
FDA Approves Use of bioCSL's Afluria Influenza Vaccine with
PharmaJet Needle-Free Injector
Bioject Inc. Expands its Global Distribution Network
Glide Pharma Completed the Successful Proof-of-Concept Study with
Octreotide
Crossject Launched Bioequivalence Clinical Study with Zeneo
(Methotrexate)
Bioject Enters Into Agreement with Fondaco
Antares Pharma's Otrexup Injection Approved by the FDA
Zogenix Received FDA Approval for 4 mg Sumavel DosePro
(Sumatriptan Injection)
3M Co. Licensed Fentanyl Transdermal Patch Technology to Stada
Arzneimittel
Adamis Pharmaceuticals Acquired Dry Powder Inhaler Technology
from 3M Co.
Bioject Medical Technologies Featured on Bloomberg International
PharmaJet's Stratis Needle-Free Injector Achieved WHO PQS
Certification
Glide Pharma Completed Design Optimization Agreement with Nypro
Healthcare
Antares Pharma Obtained U.S. Patent for Vibex Technology
Zogenix Signs Co-promotion Deal for Needle-Free Migraine
Treatment
INJEX Pharma Received FDA Clearance for the INJEX 30
Medical International Technology Gains Chinese SFDA Certification
for Med-Jet
Bioject Medical Technologies to Supply ID Pens
Zogenix and Durect Signed Development and License Agreement
CHAPTER 12 MARKETED AND PIPELINE PRODUCTS
KEY MARKETED PRODUCTS
NEEDLE-FREE INJECTORS
Antares Pharma
Medi-Jector Vision Needle-Free Injector
Vibex Pressure Assisted Auto Injection System
Pen Injector
Otrexup
Bioject Medical Technologies
Biojector 2000 Needle-Free Injection System
Vitajet Insulin Delivery System
Cool.click Needle-Free Injection System
SeroJet Needle-Free Injection System
ZetaJet Auto-Disable Needle-Free Delivery System
Endo International
Sumavel DosePro Needle-Free Delivery System
Activa Brand Products Inc.
AdvantaJet
D'Antonio Consultants International
LectraJet Disposable Syringe Jet Injector System
National Medical Products
J-Tip Needle-Free System
Medical International Technologies
Med-Jet Needle-Free System
PenJet Corp.
PenJet Needle-Free System
PharmaJet
Stratis Needle-Free System
Valeritas
Mini-Ject Needle-Free System
h-Patch
Micro-Trans
Akra Dermojet
Dermojet HR
Dermojet Polymedical with Interchangeable Injection Tips
Automatic Dermojet
Felton International
HSI-500 Needle-Free Injector
INJEX Pharma
INJEX 30 Multiple Application Needle-Free Device
Jet Syringe/Rojex Disposable, Single-Use Devices
INJEX 50 Needle-Free Injection
Keystone Industries
Syrijet Mark II
Glide Pharma
Glide SDI Drug Delivery System
The Medical House PLC (Subsidiary of Consort Medical)
mhi-500 Novel Needle-free Insulin Delivery System
Spring-Powered SQ-PEN
Bespak Drug Delivery Solutions
Shreya Life Sciences
Recojet Needle-Free Insulin Delivery Device
Merck Serono
SeroJet
Pfizer
PowderMed
Key Device Approvals by the FDA
TABLE 32 NEEDLE-FREE INJECTORS: KEY DEVICE APPROVALS BY THE FDA, 2005-2014
INHALERS
Short-Acting Bronchodilators
Corticosteroids
Combination Drugs
Key Marketed MDI Devices
TABLE 33 KEY METERED DOSE INHALERS ON THE MARKET
TRANSDERMAL PATCH
TABLE 34 TRANSDERMAL PATCH: KEY MARKETED DEVICES
OTHER NOVEL NEEDLE TECHNOLOGIES
TABLE 35 "OTHER" NOVEL NEEDLE TECHNOLOGY-BASED DEVICES ON THE MARKET
KEY PIPELINE PRODUCTS
NEEDLE-FREE INJECTORS
Antares Pharma
Vibex MTX
Vibex QS (QuickShot)
Bioject Medical Technologies
ID Pen Injector
Iject Needle-Free Injection
Jupiter Jet
Zogenix
Relday
Pulse NeedleFree Systems
Needle-Free Systems
Echo Therapeutics
Prelude SkinPrep System
American Medical Systems
JetTouch Needle-Free Injection System
Crossject Medical Technology
Zeneo Disposable, Prefilled, Needle-Free, Automatic Injection System
TABLE 36 KEY NEEDLE-FREE DEVICES IN THE PIPELINE
METERED DOSE INHALERS
Teva Pharmaceutical
Albuterol HFA MDI
Beclomethasone Dipropionate MDI
Sunovion
Levalbuterol HFA MDI
Solvay Pharmaceuticals and Nektar Therapeutics
Dronabinol MDI
GlaxoSmithKline
FP/SLM HFA MDI 50/25 mcg
TABLE 37 KEY METERED DOSE INHALERS IN THE PIPELINE
TRANSDERMAL PATCHES
Amnio Technology
PalinGen (Amniotic Membrane Patch)
ICURE Pharmaceutical Inc.
Donepezil Patch
Formoterol Patch
Oxybutynin Patch
Merz Pharmaceuticals GmbH
Overnight Intensive Patch
Mundipharma Research Ltd.
Buprenorphine Patch (Extended Release)
Tyndall National Institute
ImmuPatch
TABLE 38 KEY TRANSDERMAL PATCHES IN THE PIPELINE
OTHER NOVEL TECHNOLOGIES
Seagull Technology
SonoEye
CHAPTER 13 REGULATORY STRUCTURE
REGIONAL REGULATORY STRUCTURES
UNITED STATES
EUROPEAN UNION
TABLE 39 DIFFERENCES IN REGULATORY APPROVAL IN THE U.S. VS. EUROPE
JAPAN
OTHER ASIA
China
Hong Kong
Korea
Taiwan
India
FDA TECHNICAL CONSIDERATIONS
FDA RECALLS AND SAFETY ALERTS
OCCUPATIONAL HEALTH AND SAFETY LAWS
UNITED STATES
Needlestick Safety and Prevention Act/Blood-Borne Pathogens Standard
EUROPEAN UNION
CHAPTER 14 PRICING AND REIMBURSEMENT
REGIONAL REIMBURSEMENT STRUCTURES
UNITED STATES
Healthcare Common Procedure Coding System Code
TABLE 40 HCPCS 2014 CODE A4210: NEEDLE-FREE INJECTION
DEVICE, EACH
Insurance and Reimbursement
EUROPE
JAPAN
OTHER ASIA
MEDICAL DEVICE PRICING TRENDS
CHAPTER 15 CONCLUSIONS AND OUTLOOK FOR NEEDLE-FREE DEVICES
MAJOR MARKET INFLUENCES
SOCIAL FACTORS
TECHNOLOGICAL DEVELOPMENTS
Breath-Actuated Metered-Dose Inhalers
Novel Formulation Approaches and Technologies for Transdermal
Patches
Innovations to Create Autoinjector Syringes to Prevent Unnecessary
Contamination
Laser-Powered Needle-Free Injections
Other Advanced Transdermal Drug Delivery Technologies
Next-Generation Needle-Free Drug Injector
Next-Generation Stamp-Sized Nanopatch
DEMOGRAPHIC AND ECONOMIC TRENDS
Increasing Aging Population
TABLE 41 ESTIMATED WORLD POPULATION AND ANNUAL GROWTH BY SELECTED AGE GROUP AND SELECTED YEARS, THROUGH 2030 (MILLIONS)
FIGURE 11 ESTIMATED WORLD POPULATION BY SELECTED AGE GROUP AND SELECTED YEARS, 2000-2030 ($ MILLIONS)
TABLE 42 WORLD POPULATION BY SELECTED GEOGRAPHIC REGION, THROUGH 2030 (MILLIONS)
FIGURE 12 WORLD POPULATION BY SELECTED COUNTRy, 2000-2030 ($ MILLIONS)
U.S. Demographics
TABLE 43 U.S. POPULATION ESTIMATES AND PROJECTIONS BY AGE GROUP, THROUGH 2030 (MILLIONS)
FIGURE 13 U.S. POPULATION ESTIMATES AND PROJECTIONS BY AGE GROUP, 2000-2030 (MILLIONS)
U.S. Gender, Age and Life Expectancy
TABLE 44 ESTIMATES OF ANTICIPATED U.S. LIFE EXPECTANCY AT BIRTH AND PROJECTIONS BY GENDER, 2005-2020 (YEARS)
FIGURE 14 ESTIMATES OF ANTICIPATED U.S. LIFE EXPECTANCY AT BIRTH AND PROJECTIONS BY GENDER, 2005-2020 (YEARS)
European Demographics
TABLE 45 EUROPEAN POPULATION ESTIMATES AND PROJECTIONS BY AGE GROUP, THROUGH 2030 (MILLIONS)
FIGURE 15 EUROPEAN POPULATION ESTIMATES AND PROJECTIONS BY AGE GROUP, 2000-2030 (MILLIONS)
Japanese Demographics
TABLE 46 JAPANESE POPULATION ESTIMATES AND PROJECTIONS BY AGE GROUP, THROUGH 2030 (MILLIONS)
FIGURE 16 JAPANESE POPULATION ESTIMATES AND PROJECTIONS BY AGE GROUP, 2000-2030 (MILLIONS)
Increasing Prevalence of Diabetes
TABLE 47 GLOBAL DIABETES PREVALENCE, 2013 AND 2030
Income Growth in Developing Markets
TABLE 48 PROJECTED TRENDS IN PER CAPITA REAL GDP GROWTH BY REGION, 2012-2015 (ANNUAL AVERAGE PERCENTAGE CHANGE)
CHANGING STRUCTURE OF THE HEALTHCARE INDUSTRY
Development of Home-Care and Self Medication Devices
Developments in Health Insurance and Reimbursement
FUTURE OUTLOOK
CHAPTER 16 APPENDIX A: ABBREVIATION(S)
CHAPTER 17 APPENDIX B: VENDOR PROFILES
ACTIVA BRAND PRODUCTS INC.
AKRA DERMOJET
ALKERMES PLC
ALZA CORP.
AMNIO TECHNOLOGY LLC.
ANTARES PHARMA INC.
ARADIGM CORP.
ASTELLAS PHARMA INC.
ASTRAZENECA PLC
BATTELLE
BESPAK EUROPE LTD.
BIOJECT MEDICAL TECHNOLOGIES
BRISTOL-MYERS SQUIBB
CAMBRIDGE CONSULTANTS LTD.
CLEARSIDE BIOMEDICAL INC.
CORIUM INTERNATIONAL INC.
COVIDIEN
CROSSJECT
CYDEX PHARMACEUTICALS INC.
D'ANTONIO CONSULTANTS INTERNATIONAL
DR. REDDY'S LABORATORIES LTD.
DUOJECT MEDICAL SYSTEMS INC.
DURECT CORP.
ECHO THERAPEUTICS
ELI LILLY & CO.
ENDO INTERNATIONAL
EUROJET MEDICAL INC.
FERNDALE PHARMA GROUP INC.
FERRING PHARMACEUTICALS INC.
GERRESHEIMER AG
GLAXOSMITHKLINE PLC
GLIDE PHARMACEUTICALS TECHNOLOGIES LTD.
HASELMEIER GMBH
INJEX PHARMA AG
INTERCELL AG
JCR PHARMACEUTICALS CO. LTD.
KEYSTONE INDUSTRIES
LINEAGE THERAPEUTICS INC.
LOHMANN THERAPIE-SYSTEME AG
MALLINCKRODT PLC
MEDICAL INTERNATIONAL TECHNOLOGIES
MEDI-PATCH CLINIC
MERCK SERONO S.A.
MINNESOTA RUBBER & PLASTICS
MPI RESEARCH
MYLAN INC.
NANOPASS TECHNOLOGIES LTD.
NATIONAL MEDICAL PRODUCTS INC.
NEKTAR THERAPEUTICS
NOVARTIS
NOVEN PHARMACEUTICALS
NOVO NORDISK A/S
NYPRO INC.
OWEN MUMFORD LTD.
PACIRA PHARMACEUTICALS INC.
PATHEON
PENJET CORP.
PFIZER INC.
PHARMAJET INC.
PSIVIDA CORP.
PULSE NEEDLE-FREE SYSTEMS INC.
QLT INC.
RETRACTABLE TECHNOLOGIES INC.
SANOFI-PASTEUR
SHL GROUP AB
TAKEDA
TAPEMARK
TEAM CONSULTING LTD.
TEVA PHARMACEUTICALS INDUSTRIES LTD.
THERAJECT INC.
TRANSPHARMA MEDICAL LTD.
VALERITAS INC.
VAXXAS PTY LTD.
YPSOMED HOLDING AG
ZOGENIX
CHAPTER 18 APPENDIX C: INDUSTRY AND PROFESSIONAL
ORGANIZATIONS
AMERICAN ASSOCIATION FOR RESPIRATORY CARE
ASSOCIATION OF NEEDLE-FREE INJECTION MANUFACTURERS
CENTER FOR DEVICES AND RADIOLOGICAL HEALTH
CENTERS FOR MEDICARE & MEDICAID SERVICES
DEPARTMENT OF HEALTH AND HUMAN SERVICES
EUDAMED
FOOD AND DRUG ADMINISTRATION
IFPMA
INTERNATIONAL DIABETES FEDERATION
INTERNATIONAL ASSOCIATION FOR THE STUDY OF OBESITY
ISIPS
NATIONAL CENTER FOR BIOTECHNOLOGY INFORMATION
NATIONAL INSTITUTE ON AGING
OECD
OPTICAL SOCIETY
PATH
PMDA
USAMRIID
WORLD HEALTH ORGANIZATION

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report